EDGAR Filing Documents for 0001193125-12-272565

Form 8-K - Current report:

SEC Accession No. 0001193125-12-272565

Filing Date

2012-06-15

Accepted

2012-06-15 17:01:07

Documents

Period of Report

2012-06-11

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d367980d8k.htm	8-K	23712
2	SECURITIES PURCHASE AGREEMENT	d367980dex101.htm	EX-10.1	503297
3	CONSENT, WAIVER AND FORBEARANCE AGREEMENT	d367980dex102.htm	EX-10.2	355630
4	JOINDER TO SECURITY AGREEMENT	d367980dex103.htm	EX-10.3	407029
5	FORM OF DEBENTURE	d367980dex104.htm	EX-10.4	113398
6	PLACEMENT AGENT WARRANT	d367980dex105.htm	EX-10.5	53957
	Complete submission text file	0001193125-12-272565.txt		1458626

Mailing Address 13400 NE 20TH STREET SUITE 44 BELLEVUE WA 98005

Business Address 13400 NE 20TH STREET SUITE 44 BELLEVUE WA 98005 425-368-1050

SCOLR Pharma, Inc. (Filer) CIK: 0000934936 (see all company filings)